A novel sustained release therapy of combined VEGF and TNF-α inhibitors leads to pan-ocular protection for months after severe ocular trauma. https://www.biorxiv.org/content/10.1101/2023.03.14.531626v1?med=mas
A novel sustained release therapy of combined VEGF and TNF-α inhibitors leads to pan-ocular protection for months after severe ocular trauma. https://www.biorxiv.org/content/10.1101/2023.03.14.531626v1?med=mas